Presenting characteristics and initial outcome in 44 infants with MLL+ ALL
Feature with subcategories . | No. . |
|---|---|
| Gender | |
| Male | 19 |
| Female | 25 |
| CD10 antigen | |
| Positive | 3 |
| Negative | 41 |
| Age at diagnosis, mo | |
| Median | 5 |
| Range | 0-11 |
| WBC count, × 109/L | |
| Median | 129 |
| Range | 1.7-1524 |
| CNS invasion | 10/41 |
| Karyotype | |
| 4;11 translocation | 27 |
| 11;19 translocation | 4 |
| 9;11 translocation | 3 |
| Other | 2 |
| Normal | 8 |
| Outcome | |
| Induction failure | 1 |
| Death during induction | 2 |
| Relapse | 17 |
| BM | 12 |
| CNS | 4 |
| BM/CNS | 1 |
| Death in CCR after HSCT | 4 |
| Refusal of treatment after CR | 1 |
| CCR | 19 |
Feature with subcategories . | No. . |
|---|---|
| Gender | |
| Male | 19 |
| Female | 25 |
| CD10 antigen | |
| Positive | 3 |
| Negative | 41 |
| Age at diagnosis, mo | |
| Median | 5 |
| Range | 0-11 |
| WBC count, × 109/L | |
| Median | 129 |
| Range | 1.7-1524 |
| CNS invasion | 10/41 |
| Karyotype | |
| 4;11 translocation | 27 |
| 11;19 translocation | 4 |
| 9;11 translocation | 3 |
| Other | 2 |
| Normal | 8 |
| Outcome | |
| Induction failure | 1 |
| Death during induction | 2 |
| Relapse | 17 |
| BM | 12 |
| CNS | 4 |
| BM/CNS | 1 |
| Death in CCR after HSCT | 4 |
| Refusal of treatment after CR | 1 |
| CCR | 19 |
CCR indicates continuous complete remission.